お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ
株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
989538

世界の抗生物質市場調査レポート:薬剤クラス別、作用機序別‐2025年までの予測-COVID-19の累積的影響

Antibiotics Market Research Report by Drug Class, by Action Mechanism - Global Forecast to 2025 - Cumulative Impact of COVID-19

出版日: | 発行: 360iResearch LLP | ページ情報: 英文 193 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=107.25円
世界の抗生物質市場調査レポート:薬剤クラス別、作用機序別‐2025年までの予測-COVID-19の累積的影響
出版日: 2021年02月11日
発行: 360iResearch LLP
ページ情報: 英文 193 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の抗生物質の市場規模は、2020年に351億8,941万米ドル/ 308億5,474万ユーロとなりました。同市場は、2025年末までに479億4,729万米ドル/420億4,109万ユーロに達すると予測されています。

COVID-19は、未曾有の世界的な公衆衛生上の緊急事態であり、あらゆる業界に影響を及ぼしてきました。この長期的影響は、予測期間中に業界の成長に影響を与えると予測されています。私たちが進めている調査では、根底にあるCOVID-19の問題と今後の道筋を確実に扱うために、調査範囲を広げています。当レポートは、消費者の行動と需要の変化、購入パターン、サプライチェーンの再ルーティング、現在の市場動向、および政府の重要な介入などを考慮しながら、COVID-19について洞察を提供しています。

当レポートでは、抗生物質市場について調査し、市場の概要とともに、薬剤クラス別、作用機序別、地域別の動向、COVID-19の累積的影響、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 序文

  • 調査の目的
  • 市場セグメンテーションと範囲
  • 調査対象年
  • 通貨と価格
  • 言語
  • 制限事項
  • 利害関係者

第2章 調査手法

  • 調査プロセス
    • 定義:調査目的
    • 決定:調査デザイン
    • 準備:調査機器
    • 収集:データソース
    • 分析:データの解釈
    • 策定:データ検証
    • 公開:調査レポート
    • 繰り返し:レポートの更新
  • 調査の実行
    • 開始:調査プロセス
    • 計画:調査計画作成
    • 実行:調査実施
    • 検証:発見と分析
    • 出版物:調査報告
  • 調査成果

第3章 エグゼクティブサマリー

  • イントロダクション
  • 市場の見通し
  • タイプ別見通し
  • 製品タイプ別見通し
  • 最終用途産業別見通し
  • 地域別見通し
  • 競合他社別見通し

第4章 市場概要

  • イントロダクション
  • COVID-19の累積的影響
  • 地理的な成長機会

第5章 市場の洞察

  • 市場力学
    • 促進要因
    • 抑制要因
    • 市場機会
    • 課題
  • ポーターズファイブフォース分析
    • 新規参入業者の脅威
    • 代替品の脅威
    • 顧客の交渉力
    • 供給企業の交渉力
    • 業界の競争

第6章 世界の抗生物質市場、薬剤クラス別

  • イントロダクション
  • アミノグリコシド
  • カルバペネム
  • セファロスポリン
  • フルオロキノロン
  • マクロライド
  • ペニシリン
  • スルホンアミド

第7章 世界の抗生物質市場、作用機序別

  • イントロダクション
  • 細胞壁合成阻害剤
  • DNA合成阻害剤
  • ミコール酸阻害剤
  • タンパク質合成阻害剤
  • RNA合成阻害剤

第8章 南北アメリカの抗生物質市場

  • イントロダクション
  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第9章 アジア太平洋地域の抗生物質市場

  • イントロダクション
  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • 韓国
  • タイ

第10章 欧州、中東・アフリカの抗生物質市場

  • イントロダクション
  • フランス
  • ドイツ
  • イタリア
  • オランダ
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • アラブ首長国連邦
  • 英国

第11章 競合情勢

  • FPNVポジショニングマトリックス
    • 象限
    • 事業戦略
    • 製品の満足度
  • 市場ランキング分析
  • 市場シェア分析
  • 競合他社のSWOT分析
  • 競合シナリオ
    • 合併と買収
    • 合意、コラボレーション、およびパートナーシップ
    • 新製品の発売と強化
    • 投資と資金調達
    • 賞、表彰、拡大

第12章 企業のユーザビリティプロファイル

  • Abbott Laboratories
  • Akron Incorporated
  • Amneal Pharmaceuticals LLC
  • Astellas Pharma, Inc.
  • AstraZeneca PLC
  • Bausch Health Companies Inc
  • Bayer AG
  • Bristol Myers Squibb Company
  • Cadila Healthcare Limited
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd
  • GlaxoSmithKline PLC
  • Janssen Pharmaceuticals
  • Johnson & Johnson Services, Inc
  • KYORIN Holdings, Inc
  • LG Chem Ltd
  • Lupin Limited
  • Melinta Therapeutics, Inc
  • Merck & Co., Inc
  • MerLion Pharmaceuticals GmbH
  • Mylan N.V.
  • Novartis AG
  • Pfizer, Inc.
  • Sanofi S.A
  • Shionogi & Company, Limited
  • Sun Pharmaceutical Industries Limited
  • Teva Pharmaceutical Industries Ltd

第13章 付録

  • ディスカッションガイド
  • ライセンスと価格
図表

List of Figures

  • FIGURE 1. GLOBAL ANTIBIOTICS MARKET: RESEARCH PROCESS
  • FIGURE 2. GLOBAL ANTIBIOTICS MARKET: RESEARCH EXECUTION
  • FIGURE 3. GLOBAL ANTIBIOTICS MARKET SIZE, 2020 VS 2025 (USD MILLION)
  • FIGURE 4. GLOBAL ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2020 (USD MILLION)
  • FIGURE 5. GLOBAL ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2020 (USD MILLION)
  • FIGURE 6. GLOBAL ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
  • FIGURE 7. GLOBAL ANTIBIOTICS MARKET SIZE, 2018-2025 (USD MILLION)
  • FIGURE 8. GLOBAL ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
  • FIGURE 9. GLOBAL ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
  • FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2025
  • FIGURE 11. GLOBAL ANTIBIOTICS MARKET: MARKET DYNAMICS
  • FIGURE 12. GLOBAL ANTIBIOTICS MARKET: PORTERS FIVE FORCES ANALYSIS
  • FIGURE 13. GLOBAL ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2020 VS 2025 (%)
  • FIGURE 14. GLOBAL ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2020 VS 2025 (USD MILLION)
  • FIGURE 15. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2025
  • FIGURE 16. GLOBAL ANTIBIOTICS MARKET SIZE, BY AMINOGLYCOSIDES, 2020 VS 2025 (USD MILLION)
  • FIGURE 17. GLOBAL ANTIBIOTICS MARKET SIZE, BY CARBAPENEM, 2020 VS 2025 (USD MILLION)
  • FIGURE 18. GLOBAL ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORIN, 2020 VS 2025 (USD MILLION)
  • FIGURE 19. GLOBAL ANTIBIOTICS MARKET SIZE, BY FLUOROQUINOLONE, 2020 VS 2025 (USD MILLION)
  • FIGURE 20. GLOBAL ANTIBIOTICS MARKET SIZE, BY MACROLIDES, 2020 VS 2025 (USD MILLION)
  • FIGURE 21. GLOBAL ANTIBIOTICS MARKET SIZE, BY PENICILLIN, 2020 VS 2025 (USD MILLION)
  • FIGURE 22. GLOBAL ANTIBIOTICS MARKET SIZE, BY SULFONAMIDES, 2020 VS 2025 (USD MILLION)
  • FIGURE 23. GLOBAL ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2020 VS 2025 (%)
  • FIGURE 24. GLOBAL ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2020 VS 2025 (USD MILLION)
  • FIGURE 25. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2025
  • FIGURE 26. GLOBAL ANTIBIOTICS MARKET SIZE, BY CELL WALL SYNTHESIS INHIBITORS, 2020 VS 2025 (USD MILLION)
  • FIGURE 27. GLOBAL ANTIBIOTICS MARKET SIZE, BY DNA SYNTHESIS INHIBITORS, 2020 VS 2025 (USD MILLION)
  • FIGURE 28. GLOBAL ANTIBIOTICS MARKET SIZE, BY MYCOLIC ACID INHIBITORS, 2020 VS 2025 (USD MILLION)
  • FIGURE 29. GLOBAL ANTIBIOTICS MARKET SIZE, BY PROTEIN SYNTHESIS INHIBITORS, 2020 VS 2025 (USD MILLION)
  • FIGURE 30. GLOBAL ANTIBIOTICS MARKET SIZE, BY RNA SYNTHESIS INHIBITORS, 2020 VS 2025 (USD MILLION)
  • FIGURE 31. AMERICAS ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
  • FIGURE 32. AMERICAS ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
  • FIGURE 33. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2025
  • FIGURE 34. ARGENTINA ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 35. BRAZIL ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 36. CANADA ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 37. MEXICO ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 38. UNITED STATES ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 39. ASIA-PACIFIC ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
  • FIGURE 40. ASIA-PACIFIC ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
  • FIGURE 41. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2025
  • FIGURE 42. AUSTRALIA ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 43. CHINA ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 44. INDIA ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 45. INDONESIA ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 46. JAPAN ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 47. MALAYSIA ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 48. PHILIPPINES ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 49. SOUTH KOREA ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 50. THAILAND ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 51. EUROPE, MIDDLE EAST & AFRICA ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
  • FIGURE 52. EUROPE, MIDDLE EAST & AFRICA ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
  • FIGURE 53. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2025
  • FIGURE 54. FRANCE ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 55. GERMANY ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 56. ITALY ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 57. NETHERLANDS ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 58. QATAR ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 59. RUSSIA ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 60. SAUDI ARABIA ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 61. SOUTH AFRICA ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 62. SPAIN ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 63. UNITED ARAB EMIRATES ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 64. UNITED KINGDOM ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 65. GLOBAL ANTIBIOTICS MARKET: 360IRESEARCH™ FPNV POSITIONING MATRIX
  • FIGURE 66. GLOBAL ANTIBIOTICS MARKET: 360IRESEARCH™ MARKET SHARE ANALYSIS
  • FIGURE 67. GLOBAL ANTIBIOTICS MARKET: COMPETITOR SWOT ANALYSIS
  • FIGURE 68. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL ANTIBIOTICS MARKET, BY TYPE

List of Tables

  • TABLE 1. CURRENCY CONVERSION RATES
  • TABLE 2. GLOBAL ANTIBIOTICS MARKET SIZE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 3. GLOBAL ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 4. GLOBAL ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 5. GLOBAL ANTIBIOTICS MARKET SIZE, BY AMINOGLYCOSIDES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 6. GLOBAL ANTIBIOTICS MARKET SIZE, BY CARBAPENEM, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 7. GLOBAL ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORIN, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 8. GLOBAL ANTIBIOTICS MARKET SIZE, BY FLUOROQUINOLONE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 9. GLOBAL ANTIBIOTICS MARKET SIZE, BY MACROLIDES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 10. GLOBAL ANTIBIOTICS MARKET SIZE, BY PENICILLIN, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 11. GLOBAL ANTIBIOTICS MARKET SIZE, BY SULFONAMIDES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 12. GLOBAL ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 13. GLOBAL ANTIBIOTICS MARKET SIZE, BY CELL WALL SYNTHESIS INHIBITORS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 14. GLOBAL ANTIBIOTICS MARKET SIZE, BY DNA SYNTHESIS INHIBITORS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 15. GLOBAL ANTIBIOTICS MARKET SIZE, BY MYCOLIC ACID INHIBITORS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 16. GLOBAL ANTIBIOTICS MARKET SIZE, BY PROTEIN SYNTHESIS INHIBITORS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 17. GLOBAL ANTIBIOTICS MARKET SIZE, BY RNA SYNTHESIS INHIBITORS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 18. AMERICAS ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 19. AMERICAS ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 20. AMERICAS ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 21. ARGENTINA ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 22. ARGENTINA ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 23. BRAZIL ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 24. BRAZIL ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 25. CANADA ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 26. CANADA ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 27. MEXICO ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 28. MEXICO ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 29. UNITED STATES ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 30. UNITED STATES ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 31. ASIA-PACIFIC ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 32. ASIA-PACIFIC ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 33. ASIA-PACIFIC ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 34. AUSTRALIA ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 35. AUSTRALIA ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 36. CHINA ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 37. CHINA ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 38. INDIA ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 39. INDIA ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 40. INDONESIA ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 41. INDONESIA ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 42. JAPAN ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 43. JAPAN ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 44. MALAYSIA ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 45. MALAYSIA ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 46. PHILIPPINES ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 47. PHILIPPINES ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 48. SOUTH KOREA ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 49. SOUTH KOREA ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 50. THAILAND ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 51. THAILAND ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 52. EUROPE, MIDDLE EAST & AFRICA ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 53. EUROPE, MIDDLE EAST & AFRICA ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 54. EUROPE, MIDDLE EAST & AFRICA ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 55. FRANCE ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 56. FRANCE ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 57. GERMANY ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 58. GERMANY ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 59. ITALY ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 60. ITALY ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 61. NETHERLANDS ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 62. NETHERLANDS ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 63. QATAR ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 64. QATAR ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 65. RUSSIA ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 66. RUSSIA ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 67. SAUDI ARABIA ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 68. SAUDI ARABIA ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 69. SOUTH AFRICA ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 70. SOUTH AFRICA ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 71. SPAIN ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 72. SPAIN ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 73. UNITED ARAB EMIRATES ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 74. UNITED ARAB EMIRATES ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 75. UNITED KINGDOM ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 76. UNITED KINGDOM ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 77. GLOBAL ANTIBIOTICS MARKET: SCORES
  • TABLE 78. GLOBAL ANTIBIOTICS MARKET: BUSINESS STRATEGY
  • TABLE 79. GLOBAL ANTIBIOTICS MARKET: PRODUCT SATISFACTION
  • TABLE 80. GLOBAL ANTIBIOTICS MARKET: RANKING
  • TABLE 81. GLOBAL ANTIBIOTICS MARKET: MERGER & ACQUISITION
  • TABLE 82. GLOBAL ANTIBIOTICS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 83. GLOBAL ANTIBIOTICS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 84. GLOBAL ANTIBIOTICS MARKET: INVESTMENT & FUNDING
  • TABLE 85. GLOBAL ANTIBIOTICS MARKET: AWARD, RECOGNITION, & EXPANSION
  • TABLE 86. GLOBAL ANTIBIOTICS MARKET: LICENSE & PRICING
目次
Product Code: MRR-DA05131

Title:
Antibiotics Market Research Report by Drug Class (Aminoglycosides, Carbapenem, Cephalosporin, Fluoroquinolone, and Macrolides), by Action Mechanism (Cell Wall Synthesis Inhibitors, DNA Synthesis Inhibitors, Mycolic Acid Inhibitors, Protein Synthesis Inhibitors, and RNA Synthesis Inhibitors) - Global Forecast to 2025 - Cumulative Impact of COVID-19.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.

  • 1. The Global Antibiotics Market is expected to grow from USD 35,189.41 Million in 2020 to USD 47,947.29 Million by the end of 2025.
  • 2. The Global Antibiotics Market is expected to grow from EUR 30,854.74 Million in 2020 to EUR 42,041.09 Million by the end of 2025.
  • 3. The Global Antibiotics Market is expected to grow from GBP 27,429.93 Million in 2020 to GBP 37,374.62 Million by the end of 2025.
  • 4. The Global Antibiotics Market is expected to grow from JPY 3,755,601.74 Million in 2020 to JPY 5,117,190.82 Million by the end of 2025.
  • 5. The Global Antibiotics Market is expected to grow from AUD 51,099.70 Million in 2020 to AUD 69,625.84 Million by the end of 2025.

Market Segmentation & Coverage:

This research report categorizes the Antibiotics to forecast the revenues and analyze the trends in each of the following sub-markets:

  • Based on Drug Class, the Antibiotics Market studied across Aminoglycosides, Carbapenem, Cephalosporin, Fluoroquinolone, Macrolides, Penicillin, and Sulfonamides.
  • Based on Action Mechanism, the Antibiotics Market studied across Cell Wall Synthesis Inhibitors, DNA Synthesis Inhibitors, Mycolic Acid Inhibitors, Protein Synthesis Inhibitors, and RNA Synthesis Inhibitors.
  • Based on Geography, the Antibiotics Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Company Usability Profiles:

The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Antibiotics Market including Abbott Laboratories, Akron Incorporated, Amneal Pharmaceuticals LLC, Astellas Pharma, Inc., AstraZeneca PLC, Bausch Health Companies Inc, Bayer AG, Bristol Myers Squibb Company, Cadila Healthcare Limited, Eli Lilly and Company, F. Hoffmann-La Roche Ltd, GlaxoSmithKline PLC, Janssen Pharmaceuticals, Johnson & Johnson Services, Inc, KYORIN Holdings, Inc, LG Chem Ltd, Lupin Limited, Melinta Therapeutics, Inc, Merck & Co., Inc, MerLion Pharmaceuticals GmbH, Mylan N.V., Novartis AG, Pfizer, Inc., Sanofi S.A, Shionogi & Company, Limited, Sun Pharmaceutical Industries Limited, and Teva Pharmaceutical Industries Ltd.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.

360iResearch™ FPNV Positioning Matrix:

The 360iResearch™ FPNV Positioning Matrix evaluates and categorizes the vendors in the Antibiotics Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

360iResearch™ Competitive Strategic Window:

The 360iResearch™ Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch™ Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.

The report provides insights on the following pointers:

  • 1. Market Penetration: Provides comprehensive information on the market offered by the key players
  • 2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
  • 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
  • 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
  • 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments

The report answers questions such as:

  • 1. What is the market size and forecast of the Global Antibiotics Market?
  • 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Antibiotics Market during the forecast period?
  • 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Antibiotics Market?
  • 4. What is the competitive strategic window for opportunities in the Global Antibiotics Market?
  • 5. What are the technology trends and regulatory frameworks in the Global Antibiotics Market?
  • 6. What are the modes and strategic moves considered suitable for entering the Global Antibiotics Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Stakeholders

2. Research Methodology

  • 2.1. Research Process
    • 2.1.1. Define: Research Objective
    • 2.1.2. Determine: Research Design
    • 2.1.3. Prepare: Research Instrument
    • 2.1.4. Collect: Data Source
    • 2.1.5. Analyze: Data Interpretation
    • 2.1.6. Formulate: Data Verification
    • 2.1.7. Publish: Research Report
    • 2.1.8. Repeat: Report Update
  • 2.2. Research Execution
    • 2.2.1. Initiation: Research Process
    • 2.2.2. Planning: Develop Research Plan
    • 2.2.3. Execution: Conduct Research
    • 2.2.4. Verification: Finding & Analysis
    • 2.2.5. Publication: Research Report
  • 2.3. Research Outcome

3. Executive Summary

  • 3.1. Introduction
  • 3.2. Market Outlook
  • 3.3. Drug Class Outlook
  • 3.4. Action Mechanism Outlook
  • 3.5. Geography Outlook
  • 3.6. Competitor Outlook

4. Market Overview

  • 4.1. Introduction
  • 4.2. Cumulative Impact of COVID-19

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of patients suffering from infectious diseases
      • 5.1.1.2. Development of novel strategies for new antibiotics and a large number of clinical trials
      • 5.1.1.3. Extended consumption in low and middle-income countries
    • 5.1.2. Restraints
      • 5.1.2.1. Misuse of antibiotics
    • 5.1.3. Opportunities
      • 5.1.3.1. Advanced prospect molecules and novel combination therapies to treat antibiotic-resistant microbial infections
      • 5.1.3.2. Growing in R&D of new drugs
    • 5.1.4. Challenges
      • 5.1.4.1. Side effects caused by the usage of antibiotic drugs
  • 5.2. Porters Five Forces Analysis
    • 5.2.1. Threat of New Entrants
    • 5.2.2. Threat of Substitutes
    • 5.2.3. Bargaining Power of Customers
    • 5.2.4. Bargaining Power of Suppliers
    • 5.2.5. Industry Rivalry

6. Global Antibiotics Market, By Drug Class

  • 6.1. Introduction
  • 6.2. Aminoglycosides
  • 6.3. Carbapenem
  • 6.4. Cephalosporin
  • 6.5. Fluoroquinolone
  • 6.6. Macrolides
  • 6.7. Penicillin
  • 6.8. Sulfonamides

7. Global Antibiotics Market, By Action Mechanism

  • 7.1. Introduction
  • 7.2. Cell Wall Synthesis Inhibitors
  • 7.3. DNA Synthesis Inhibitors
  • 7.4. Mycolic Acid Inhibitors
  • 7.5. Protein Synthesis Inhibitors
  • 7.6. RNA Synthesis Inhibitors

8. Americas Antibiotics Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Antibiotics Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. South Korea
  • 9.10. Thailand

10. Europe, Middle East & Africa Antibiotics Market

  • 10.1. Introduction
  • 10.2. France
  • 10.3. Germany
  • 10.4. Italy
  • 10.5. Netherlands
  • 10.6. Qatar
  • 10.7. Russia
  • 10.8. Saudi Arabia
  • 10.9. South Africa
  • 10.10. Spain
  • 10.11. United Arab Emirates
  • 10.12. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
    • 11.1.1. Quadrants
    • 11.1.2. Business Strategy
    • 11.1.3. Product Satisfaction
  • 11.2. Market Ranking Analysis
  • 11.3. Market Share Analysis
  • 11.4. Competitor SWOT Analysis
  • 11.5. Competitive Scenario
    • 11.5.1. Merger & Acquisition
    • 11.5.2. Agreement, Collaboration, & Partnership
    • 11.5.3. New Product Launch & Enhancement
    • 11.5.4. Investment & Funding
    • 11.5.5. Award, Recognition, & Expansion

12. Company Usability Profiles

  • 12.1. Abbott Laboratories
  • 12.2. Akron Incorporated
  • 12.3. Amneal Pharmaceuticals LLC
  • 12.4. Astellas Pharma, Inc.
  • 12.5. AstraZeneca PLC
  • 12.6. Bausch Health Companies Inc
  • 12.7. Bayer AG
  • 12.8. Bristol Myers Squibb Company
  • 12.9. Cadila Healthcare Limited
  • 12.10. Eli Lilly and Company
  • 12.11. F. Hoffmann-La Roche Ltd
  • 12.12. GlaxoSmithKline PLC
  • 12.13. Janssen Pharmaceuticals
  • 12.14. Johnson & Johnson Services, Inc
  • 12.15. KYORIN Holdings, Inc
  • 12.16. LG Chem Ltd
  • 12.17. Lupin Limited
  • 12.18. Melinta Therapeutics, Inc
  • 12.19. Merck & Co., Inc
  • 12.20. MerLion Pharmaceuticals GmbH
  • 12.21. Mylan N.V.
  • 12.22. Novartis AG
  • 12.23. Pfizer, Inc.
  • 12.24. Sanofi S.A
  • 12.25. Shionogi & Company, Limited
  • 12.26. Sun Pharmaceutical Industries Limited
  • 12.27. Teva Pharmaceutical Industries Ltd

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.